Androgen Blocker Works in Prostate Ca

June 2, 2014 8:52 PM

16 0

CHICAGO -- A drug that blocks the androgen receptor can markedly delay chemotherapy in men with progressive prostate cancer despite androgen deprivation therapy (ADT), a researcher said.

In a randomized, phase III trial, enzalutamide (Xtandi) reduced the risk of needing chemotherapy by 65% compared with placebo, according to Tomasz Beer, MD, of Oregon Health and Science University in Portland.

Read more

To category page